PharmaTimes Profile Banner
PharmaTimes Profile
PharmaTimes

@PharmaTimes

Followers
58K
Following
167
Media
1K
Statuses
22K

PharmaTimes Media Ltd. Subscribe online. Print. Online. Digital. #pharma #news #health #digitalhealth #mhealth #NHS #marketers #comms #clinical #jobs #MSL

Surrey, UK
Joined June 2009
Don't wanna be here? Send us removal request.
@PharmaTimes
PharmaTimes
6 hours
Porosome Therapeutics unveils breakthrough Alzheimer’s research
Tweet card summary image
pharmatimes.com
FDA validation and AI-designed therapies mark major shift in treatment strategy
0
0
3
@PharmaTimes
PharmaTimes
7 hours
Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
Tweet card summary image
pharmatimes.com
New oral GLP-1 agonist aims to reshape chronic weight management
0
1
0
@PharmaTimes
PharmaTimes
1 day
Gedeon Richter launches Nalvee in UK to expand HRT options for menopause
Tweet card summary image
pharmatimes.com
Dydrogesterone-only tablet returns after 17-year absence to support personalised care
0
0
1
@PharmaTimes
PharmaTimes
1 day
Bath researchers develop pill-based alternative to injections
Tweet card summary image
pharmatimes.com
New drug delivery system could transform treatment for chronic conditions
0
0
0
@PharmaTimes
PharmaTimes
1 day
The #PharmaTimes Communications Awards’ Aspiring Communications Manager of the Year category is still open for entry!. Enter here: Find out more about our categories here: #PTCA
Tweet media one
0
0
1
@PharmaTimes
PharmaTimes
2 days
Entries close today for the #PharmaTimes Clinical Researcher of the Year – The Americas Awards competition. Enter here: If you have any questions or queries regarding your entry, please contact Luci Sargood - luci.sargood@pharmatimes.com. #PTCROY
Tweet media one
0
0
0
@PharmaTimes
PharmaTimes
2 days
US$30.9 million strategic equity deal strengthens Everest’s oncology platform
Tweet card summary image
pharmatimes.com
US$30.9 million strategic equity deal strengthens oncology platform
0
0
1
@PharmaTimes
PharmaTimes
2 days
Microbiotica completes recruitment for phase 1b ulcerative colitis trial
Tweet card summary image
pharmatimes.com
MB310 study investigates safety and efficacy of precision microbiome therapy
0
0
1
@PharmaTimes
PharmaTimes
5 days
This is your final opportunity to enter the #PharmaTimes Clinical Researcher of the Year – The Americas Awards competition, with entries closing in three days. Enter here: Find out more about our categories here: #PTCROY
Tweet media one
0
0
3
@PharmaTimes
PharmaTimes
6 days
RT @ehpawards: The Excellence in Healthcare Partnerships (EHP) Awards are officially open for entry!. Celebrate and showcase innovative hea….
0
1
0
@PharmaTimes
PharmaTimes
6 days
Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease
Tweet card summary image
pharmatimes.com
Four-year treatment slows cognitive decline with consistent safety profile
0
0
0
@PharmaTimes
PharmaTimes
6 days
Moderna wins EU approval for updated COVID-19 vaccine
Tweet card summary image
pharmatimes.com
Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season
0
1
2
@PharmaTimes
PharmaTimes
6 days
Natalie Pastor, Senior Key Account Manager hATTR, comments on why she would recommend entering the #PharmaTimes Marketer Awards. Enter here: Find out more about our categories here: #PTMOY
Tweet media one
0
0
0
@PharmaTimes
PharmaTimes
7 days
NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
Tweet card summary image
pharmatimes.com
Imfinzi and Imjudo combination recommended as first-line treatment
0
0
0
@PharmaTimes
PharmaTimes
7 days
Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial
Tweet card summary image
pharmatimes.com
Alfasigma to seek regulatory approval following OLINGUITO study success
0
0
0
@PharmaTimes
PharmaTimes
8 days
PharmaTimes Clinical Researcher of the Year – The Americas
Tweet card summary image
pharmatimes.com
Still time to enter – but not much!
0
0
0
@PharmaTimes
PharmaTimes
8 days
Exonate to launch phase 2b trial of EXN407 for diabetic eye disease
Tweet card summary image
pharmatimes.com
CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy
0
0
0
@PharmaTimes
PharmaTimes
8 days
The #PharmaTimes Communications Awards’ NHS Challenge category is still open for entry!. Enter here: Find out more about our categories here: #PTCA
Tweet media one
0
0
1
@PharmaTimes
PharmaTimes
9 days
There is still time to enter - entry closes in one week for the 2025 PharmaTimes Clinical Researcher of the Year - The Americas!. Enter here: Find out more about our categories here: #PTCROY
Tweet media one
0
0
2